Cargando…
PCPA protects against monocrotaline-induced pulmonary arterial remodeling in rats: potential roles of connective tissue growth factor
The purpose of this study was to investigate the mechanism of monocrotaline (MCT)-induced pulmonary artery hypertension (PAH) and determine whether 4-chloro-DL-phenylalanine (PCPA) could inhibit pulmonary arterial remodeling associated with connective tissue growth factor (CTGF) expression and downs...
Autores principales: | Bai, Yang, Li, Zhong-Xia, Zhao, Yue-Tong, Liu, Mo, Wang, Yun, Lian, Guo-Chao, Zhao, Qi, Wang, Huai-Liang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5762349/ https://www.ncbi.nlm.nih.gov/pubmed/29340081 http://dx.doi.org/10.18632/oncotarget.22882 |
Ejemplares similares
-
The protective effects of PCPA against monocrotaline-induced pulmonary arterial hypertension are mediated through the downregulation of NFAT-1 and NF-κB
por: Bai, Yang, et al.
Publicado: (2017) -
Astragaloside IV blocks monocrotaline-induced pulmonary arterial hypertension by improving inflammation and pulmonary artery remodeling
por: Jin, Haifeng, et al.
Publicado: (2021) -
Effects of renal denervation on monocrotaline induced pulmonary remodeling
por: Liu, Qian, et al.
Publicado: (2017) -
Formononetin attenuates monocrotaline-induced pulmonary arterial hypertension via inhibiting pulmonary vascular remodeling in rats
por: Cai, Changhong, et al.
Publicado: (2019) -
Activation of AMPK Prevents Monocrotaline-Induced Extracellular Matrix Remodeling of Pulmonary Artery
por: Li, Shaojun, et al.
Publicado: (2016)